These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35340407)

  • 1. Regenerative therapy by using mesenchymal stem cells-derived exosomes in COVID-19 treatment. The potential role and underlying mechanisms.
    Kaffash Farkhad N; Mahmoudi A; Mahdipour E
    Regen Ther; 2022 Jun; 20():61-71. PubMed ID: 35340407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
    Gardin C; Ferroni L; Chachques JC; Zavan B
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32858940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on mesenchymal stem/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19.
    Klimczak A
    World J Stem Cells; 2020 Sep; 12(9):1013-1022. PubMed ID: 33033561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
    Tsuchiya A; Takeuchi S; Iwasawa T; Kumagai M; Sato T; Motegi S; Ishii Y; Koseki Y; Tomiyoshi K; Natsui K; Takeda N; Yoshida Y; Yamazaki F; Kojima Y; Watanabe Y; Kimura N; Tominaga K; Kamimura H; Takamura M; Terai S
    Inflamm Regen; 2020; 40():14. PubMed ID: 32582401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects.
    Abdelgawad M; Bakry NS; Farghali AA; Abdel-Latif A; Lotfy A
    Stem Cell Res Ther; 2021 Aug; 12(1):469. PubMed ID: 34419143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential therapeutic effects and nano-based delivery systems of mesenchymal stem cells and their isolated exosomes to alleviate acute respiratory distress syndrome caused by COVID-19.
    Ghiasi M; Kheirandish Zarandi P; Dayani A; Salimi A; Shokri E
    Regen Ther; 2024 Dec; 27():319-328. PubMed ID: 38650667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19.
    Hou XY; Danzeng LM; Wu YL; Ma QH; Yu Z; Li MY; Li LS
    World J Stem Cells; 2024 Apr; 16(4):353-374. PubMed ID: 38690515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes contribution in COVID-19 patients' treatment.
    Mazini L; Rochette L; Malka G
    J Transl Med; 2021 May; 19(1):234. PubMed ID: 34059065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.
    Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P
    Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs.
    Jamshidi E; Babajani A; Soltani P; Niknejad H
    Stem Cell Rev Rep; 2021 Feb; 17(1):176-192. PubMed ID: 33432484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments.
    Gurunathan S; Kang MH; Kim JH
    Front Immunol; 2021; 12():716407. PubMed ID: 34394121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
    Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
    Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and the role of stem cells.
    Alanazi A
    Regen Ther; 2021 Dec; 18():334-338. PubMed ID: 34462723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
    Cheng X; Jiang M; Long L; Meng J
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
    [No Abstract]   [Full Text] [Related]  

  • 15. MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak.
    Jamalkhah M; Asaadi Y; Azangou-Khyavy M; Khanali J; Soleimani M; Kiani J; Arefian E
    J Transl Med; 2021 Apr; 19(1):164. PubMed ID: 33888147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
    Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
    BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of Mesenchymal Stem Cells: A Potential Adjuvant Therapy for COVID-19.
    Zhu Y; Geng S; Li Q; Jiang H
    Front Bioeng Biotechnol; 2020; 8():557652. PubMed ID: 33224928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease.
    Gentile P; Sterodimas A; Pizzicannella J; Calabrese C; Garcovich S
    Aging Dis; 2020 Oct; 11(5):1191-1201. PubMed ID: 33014532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS).
    Lanzoni G; Linetsky E; Correa D; Alvarez RA; Marttos A; Hirani K; Cayetano SM; Castro JG; Paidas MJ; Efantis Potter J; Xu X; Glassberg M; Tan J; Patel AN; Goldstein B; Kenyon NS; Baidal D; Alejandro R; Vianna R; Ruiz P; Caplan AI; Ricordi C
    CellR4 Repair Replace Regen Reprogram; 2020; 8():. PubMed ID: 34164564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection.
    Avanzini MA; Mura M; Percivalle E; Bastaroli F; Croce S; Valsecchi C; Lenta E; Nykjaer G; Cassaniti I; Bagnarino J; Baldanti F; Zecca M; Comoli P; Gnecchi M
    Stem Cells Transl Med; 2021 Apr; 10(4):636-642. PubMed ID: 33188579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.